Skip to content

Lowest price ever on Microdosing Tirzepatide | $239/month $159/month

Our science

Microdosing GLP‑1

A lower‑dose approach to GLP‑1 medications, studied for appetite, moderate weight support, and the inflammation and metabolic pathways tied to healthy aging.

Good to know

GLP-1 medications work through receptors in the brain, gut, and immune system, shaping appetite, blood sugar, and inflammation.1

Microdosing uses lower amounts, a potential way to ease into GLP-1 care while researchers study its role in healthy aging.2

The FDA has not reviewed these statements or approved this compounded product for any use, or for safety, efficacy, or quality.

What Microdosing GLP‑1 may support

The idea behind microdosing is to use less to gently influence the same appetite, metabolic, and inflammatory pathways targeted at standard doses, with a more gradual approach.
May help quiet appetite and cravings without aiming for the stronger appetite suppression of standard dosing.6
May support more moderate weight goals with a lower-dose approach.4
GLP-1 pathways are being studied for inflammation, glucose regulation, and metabolic health.2
Available as clinician-guided Semaglutide or Tirzepatide plans with personalized dosing and ongoing adjustments.

How Microdosing GLP‑1 works

Think of GLP-1 signaling like a volume dial for hunger and metabolism. Microdosing may turn that dial more gently, using a lower dose to potentially influence appetite, cravings, inflammation, and blood sugar with potentially fewer side effects and a more gradual approach.1
Explore Microdosing GLP‑1

GLP-1 signaling reaches three systems at once: the brain, gut, and immune system.1

3 systems
Prescription products require an online evaluation with a licensed provider who will determine if a prescription is appropriate. Compounded products come from a licensed compounding pharmacy. The FDA has not reviewed these statements or approved this compounded product for any use, or for safety, efficacy, or quality.

Microdosing GLP‑1 benefits

What the science says about lower-dose approaches with GLP-1s and the evidence behind each.

What we still don’t know

We believe in full transparency. Here’s what Microdosing GLP-1 research doesn’t yet answer.

Our GLP‑1 research is shaping what comes next

Microdosing is still an emerging approach, which is exactly why we’re studying it. Our Stanford PhD-led Research Team is running one of the first longevity-focused clinical trials on lower-dose GLP‑1 use, while our in-house clinicians bring those learnings into real-world care.
One of the first longevity-focused clinical trials on GLP‑1 microdosing
Stanford PhD-led Research Team behind 11+ longevity clinical trials and 9 peer-reviewed publications
Read our Research

Microdosing GLP‑1 educational content medically reviewed by our experts

Dr. Jenell Decker, MD

Medical Director

Trusted expert in preventative care, integrative medicine, and longevity driven clinical practice.
Marshall University Joan C. Edwards School of Medicine
East Carolina University
Concord University

Don’t know where to start?

Take our quick assessment to get personalized recommendations based on your goals and where you are in your longevity journey.

Frequently asked questions

01 Is Microdosing GLP‑1 FDA‑approved?

No. Some brand name GLP-1 medications are FDA‑approved for type 2 diabetes and weight management, but microdosing is off‑label. The FDA has not reviewed these statements or approved this compounded product for any use, or for safety, efficacy, or quality.7

02 What is Microdosing GLP‑1?

It’s using lower-than-standard amounts of a GLP-1 medication. Some people choose it to support appetite, moderate weight goals, and metabolic health with a gentler on-ramp. A provider decides whether it’s appropriate for you.

03 Do the studies use Microdosing GLP‑1?

Mostly no. Most GLP-1 research uses standard or low clinical doses, not AgelessRx’s compounded microdose. The studies describe GLP-1 medications generally, and individual results vary.

Some of these studies used the brand name version of this drug. However, our medical experts expect that the compounded product offered here may sustain many of the same risks and benefits that brand name drug has shown.

04 How will I know if Microdosing GLP‑1 is working?

People track appetite, cravings, weight, energy, and how they feel over several weeks. Response varies from person to person, and a provider adjusts the plan with you.

05 Semaglutide or Tirzepatide?

Both are GLP-1-based. Tirzepatide also acts on a second gut hormone, GIP. A clinician helps you choose based on your goals and health history.

06 Who should not use Microdosing GLP‑1?

It isn’t right for everyone. People with a personal or family history of medullary thyroid cancer or MEN2, or a history of pancreatitis, should not use GLP-1 medications, and it isn’t for use in pregnancy. A provider reviews your history first.

07 What else should I know before starting Microdosing GLP‑1?

Prescription products require an online evaluation with a licensed provider who will determine if a prescription is appropriate. Risks and benefits outlined on agelessrx.com may be based on third-party studies.

Actual product packaging may appear differently than shown. Compounded products come from a licensed compounding pharmacy.